Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Gerresheimer Extends Medical Device Operations

By R&D Editors | March 10, 2014

Gerresheimer AG, a specialty glass and plastics partner of the pharma and healthcare industry, is extending its production capacity for medical plastic systems by 60,000 ft2 at its plant in Peachtree City, Ga. Two thirds of the additional production area will be ISO class 8 cleanroom space.

Production of new medical devices will start right after completion of the infrastructural enlargements. Gerresheimer is investing several million dollars in the project, which will create around 120 additional jobs.

“We’re experiencing worldwide growth in demand for user friendly, safe, and easy to use medical devices such as inhalers and insulin pens. As a result of this growth, and new customer projects, our excellent plant in Peachtree City will be significantly increasing its production capacity. There are a great many opportunities for us in this business segment in the U.S. and our Peachtree City facility will play a crucial role in helping us to exploit them. We greatly appreciate the generous support of the state and local authorities in Georgia in this challenging project,” says Andreas Schütte, member of the management board of Gerresheimer AG with responsibility for the Plastics & Devices Division.

“Georgia’s healthcare industry is uniquely poised to help Gerresheimer grow,” says Georgia Governor Nathan Deal. “This leading global company is taking advantage of an eager, skilled workforce and an advanced life science and healthcare ecosystem. Our state is the ideal location to support Gerresheimer’s newest expansion.”

Gerresheimer established its first Peachtree City production facility in 1993 and expanded it in 2009 with the establishment of a Technical Competence Center. The plant in Peachtree City is part of Gerresheimer’s Medical Plastic Systems business unit. Gerresheimer Headquarters is based in Düsseldorf, Germany. Peachtree City and the other plants in this business unit develop, industrialize, manufacture, and assemble customer-specific devices such as inhalers, insulin pens, lancets, and various diagnostic systems.

Release Date: March 10, 2014
Source: Gerresheimer 

Related Articles Read More >

2025 R&D layoffs tracker hits 132,075 as Amazon CEO signals AI will cut more jobs
Probiotics power a bioresorbable battery that can run from 4 to 100+ minutes
Health-related innovation in Morocco highlighted by resident inventor patenting activity
ARPA-H funds $29M Ginkgo-led project to reshore pharma supply chains using wheat germ tech
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE